Amy M. Scurlock

High Impact

Professor

University of Arkansas for Medical Sciences

faculty

Peds Pediatrics, College of Medicine

35 h-index 158 pubs 6,910 cited

Research Areas

Links

ORCID Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Amy M. Scurlock, M.D. studies mucosal immune responses in models of food allergy and eosinophilic gastrointestinal disorders. Her clinical interests encompass a range of allergic and immunologic conditions, including food allergy, atopic dermatitis, eosinophilic esophagitis, and primary immunodeficiency. She also focuses on newborn screening and the long-term follow-up of infants diagnosed with severe combined immunodeficiency (SCID) and T-cell lymphopenia.

Dr. Scurlock's research has resulted in publications addressing topics such as the treatment of multiple food allergies with omalizumab, the safety and efficacy of epicutaneous immunotherapy for peanut allergy, and the role of allergen-specific T cells in food allergy. She has also investigated food insecurity among individuals with food allergies and the preparation of patients for oral immunotherapy. Her work has been recognized with a designation as a highly cited researcher, indicated by an h-index of 35 and over 6,900 citations across 158 publications. She leads a research group and collaborates with researchers at the University of Arkansas for Medical Sciences, including Stacie M. Jones and Emily Seminara.

Research Overview

Amy M. Scurlock, M.D. is an Associate Professor of Pediatrics at the University of Arkansas for Medical Sciences and Arkansas Children's Hospital. Dr. Scurlock is also a researcher at Arkansas Children's Hospital Research Institute. Dr. Scurlock received her M.D. in 1998 from the University of Arkansas for Medical Sciences. She completed a residency in Pediatrics at UAMS/ACH in 2001 and served as Chief Resident until 2002. She completed her Allergy-Immunology Fellowship Training at Duke University Medical Center in Durham North Carolina in 2004. Dr. Scurlock joined the UAMS faculty in August 2004 as a member of the Division of Pediatric Allergy/Immunology within the Department of Pediatrics. Dr. Scurlock's clinical interests include allergic and immunologic diseases such as food allergy, atopic dermatitis, eosinophilic esophagitis and primary immunodeficiency. She also has interest in newborn screening and long-term follow-up for infants with SCID and T-cell lymphopenia. Her research interests are focused on evaluation of mucosal immune responses in models of food allergy and eosinophilic gastrointestinal disorders. Dr. Scurlock is a member of the American Academy of Allergy Asthma and Immunology (AAAAI), Society for Mucosal Immunology, Society for Pediatric Research, Clinical Immunology Society, and American Academy of Pediatrics. She is board certified in both Pediatrics and Allergy-Immunology. Some of the UAMS College of Medicine faculty members provide pediatric patient care at Arkansas Children's Hospital. In addition, a wide range of pediatric services are provided in more than 35 subspecialties around Arkansas in locations such as the Schmieding Developmental Center in Springdale and the James L. Dennis Developmental Center in Little Rock. To make an appointment at Arkansas Children's Hospital, please call 501-364-4000.

Metrics

h-index: 35
Publications: 158
Citations: 6,910

Selected Publications

Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies (2025) DOI
Introduction of allergenic foods after treatment with omalizumab (2025) DOI
Introduction Of Allergenic Foods After Treatment With Omalizumab (2025) DOI
Multicenter food protein–induced enterocolitis syndrome (FPIES) data collection: Leveraging a REDCap FPIES registry for improved clinical outcomes (2025) DOI
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent (2024) DOI
Long-term walnut oral immunotherapy induces shifts in serum antibody binding patterns to walnut and cross-reactive tree nuts (2024) DOI
Long-Term Follow-up after IMPACT Peanut Oral Immunotherapy Clinical Trial (2024) DOI
Survey of Arkansas Pediatric Providers on the Application of the NIH/NIAID Addendum Guidelines for the Prevention of Peanut Allergy in the United States (2024) DOI
Food insecurity and allergic diseases: A call to collective action (2023) DOI
Peanut allergy (2023) DOI
The SunBEAm birth cohort: Protocol design (2023) DOI
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy (2023) DOI
Efficacy and Safety of Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Subjects Aged 1-3 Years With and Without Atopic Dermatitis in the EPITOPE Study (2023) DOI
Food insecurity in children and adults with food allergies (2022) DOI
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials (2022) DOI

Grants & Funding

FARE Network UAMS ACHRI Flow Through Principal Investigator
Immunoregulatory Networks in Chlamydia Genital Tract Infection NIH Principal Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator
FARE Network UAMS ACHRI Flow Through Principal Investigator
No FP attached UAMS ACHRI Flow Through Principal Investigator